跳至主要内容
临床试验/NCT06280430
NCT06280430尚未招募不适用

Serum Elafin :A Biomarker in Behcet Disease and Its Relation to Vascular Involvement and Disease Activity

Assiut University0 个研究点目标入组 90 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
主要终点
To measure the level of serum elafin in behcet patients and compare it with control group

研究概览

简要总结

To measure the level of serum elafin in patients with behcet disease and to assess the correlation between serum elafin and vascular affection and their relation with disease activity

详细描述

Behcet disease is a chronic multi systemic inflammatory disease characterized by recurrent oral and genital ulcers and multiple systemic affection . Elafin is a serine protease inhibitor produced mainly by epithelial cells . previous studies documented the role of serum elafin in pathogenesis of behcet disease.vascular complications may be one if the earliest manifestation leading to the diagnosis of behcet disease.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed as behcet disease Age (20-45)

排除标准

  • age <20 and >45 Other autoimmune diseases Risk factors (ischemic heart disease, diabetes) Chronic conditions (malignancy, chronic kidney disease)

结局指标

主要结局

To measure the level of serum elafin in behcet patients and compare it with control group

时间窗: Within 1year

Measure the level of serum elafin in behcet and its relation to disease activity and vascular involvement

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lobna Amer Araby Ahmed

Assuit

Assiut University

相似试验